Preoperative Characteristics |
Preoperative
Characteristics |
Preoperative Characteristics |
Preoperative Characteristics |
Age (years) |
59 (50, 67) |
67 (58, 76) |
<0.0001 |
Male |
187 (68.0) |
86 (63.7) |
0.386 |
Non-white race |
56 (20.4) |
38 (28.2) |
0.078 |
Body Mass Index (kg/m2) |
25 (23, 28) |
25 (23, 28) |
0.784 |
New York Heart Association Class |
|
|
0.947 |
I |
35 (20.8) |
19 (22.1) |
|
II |
73 (43.5) |
34 (39.5) |
|
III |
45 (26.8) |
25 (29.1) |
|
IV |
15 (8.9) |
8 (9.3) |
|
Diabetes |
30 (11.7) |
6 (4.8) |
0.029 |
Atrial fibrillation |
30 (18.9) |
13 (15.9) |
0.563 |
History of Congestive Heart Failure |
99 (38.5) |
52 (41.3) |
0.605 |
Hyperlipidemia |
73 (39.7) |
27 (31.8) |
0.212 |
Hypertension |
154 (59.5) |
64 (50.8) |
0.090 |
Chronic Obstructive Pulmonary Disease |
21 (5.7) |
16 (13.0) |
0.166 |
Prior myocardial infarction |
15 (6.3) |
8 (6.9) |
0.816 |
Prior cerebrovascular accident |
11 (4.6) |
3 (3.7) |
0.285 |
Renal Insufficiency |
11 (4.3) |
3 (2.4) |
0.366 |
Renal failure requiring renal replacement therapy |
8 (2.1) |
1 (0.3) |
0.165 |
Ejection Fraction (%) |
61 (57, 66) |
60 (50, 65) |
0.0004 |
Previous cardiac surgery |
4 (1.5) |
15 (11.1) |
<0.0001 |
Prior mitral valve surgery |
2 (0.7) |
5 (3.7) |
0.029 |
CABG |
0 (0) |
7 (5.2) |
0.0001 |
Any valve |
4 (1.5) |
9 (6.7) |
0.048 |
Preoperative Mitral Valve Assessment (Echocardiogram) |
Preoperative Mitral Valve Assessment (Echocardiogram) |
Preoperative Mitral Valve Assessment (Echocardiogram) |
Preoperative Mitral Valve Assessment
(Echocardiogram) |
Leaflet involvement |
|
|
|
Anterior |
20 (7.3) |
32 (23.7) |
<0.0001 |
Posterior |
215 (78.8) |
92 (68.2) |
|
Anterior and Posterior |
38 (13.0) |
11 (8.1) |
|
Preoperative MR grade |
|
|
0.0002 |
Mild |
2 (0.7) |
5 (3.8) |
|
Moderate |
30 (7.4) |
32 (24.2) |
|
Severe |
238 (88.1) |
95 (72.0) |
|
Etiology of mitral valve disease |
|
|
<0.0001 |
Degenerative |
259 (94.2) |
104 (77.0) |
|
Other |
16 (5.8) |
31 (23.0) |
|